Clinical Trial Update: A Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia [Phase 2]

View source ↗

Summary

Phase 2 pilot study assessing LCQ908 alone and with fenofibrate or Lovaza in patients with severe hypertriglyceridemia due to Non-Familial Chylomicronemia Syndr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non Familial Chylomicronemia Syndrome

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• LCQ908
• LOVAZA (OMEGA-3-ACID ETHYL ESTERS)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Non Familial Chylocmicronemia Syndrome (Non-FCS) | Phase 2 | Status: COMPLETED